Carbogen Amcis is a leading provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development.

The integrated services offered by the company provide innovative, timely and safe drug development solutions that allow customers to make the best use of their available resources. Carbogen Amcis focus is on supporting the development process from bench to market. The breadth of capabilities spans from?contract chemical process research and?development?to the?supply of Active Pharmaceutical Ingredients (APIs) and?drug products for preclinical studies, clinical trials and commercial use.

As part of a formal collaboration with UK-based ADC Biotechnology (ADC Bio) the company provides customers with seamless development and manufacturing services for antibody drug conjugates (ADCs) ? a key anti-cancer treatment platform. The two companies offer a complete range of services to customers for the development, scale-up, manufacturing and formulation of protein-based drug conjugates.

Hauptstrasse 171
CH-4416 Bubendorf
Switzerland

Web: Carbogen Amcis

Advertisement #3

Advertisement #5